牲畜驅蟲劑市場機會、成長動力、產業趨勢分析與預測 2025 - 2034

Livestock Dewormers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2024年12月14日 | 出版商:

Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球牲畜驅蟲劑市場價值為 79 億美元，預計 2025 年至 2034 年期間的複合年成長率為 4.8%。肉類和牛奶消費量的增加需要有效的畜群健康管理來最大限度地提高生產力。牲畜體內的寄生蟲感染會嚴重阻礙其生長和產量，因此驅蟲劑在牲畜保健中起著至關重要的作用。嚴格的食品安全法規、政府對獸醫健康的支持以及農民對寄生蟲感染造成的經濟損失的認知不斷提高，正在促進市場的發展。亞太、拉丁美洲和非洲的發展中地區也做出了巨大貢獻，牲畜數量的增加和獸醫基礎設施的投資推動了需求。

牲畜驅蟲藥或驅蟲藥針對的是牛、羊、山羊、豬和家禽等動物體內的蛔蟲、絛蟲和吸蟲等寄生蟲。牛市佔據了市場主導地位，到 2024 年市場規模將達到 36 億美元。集約化農業實踐的採用和對食品安全的日益重視進一步推動了這一領域的突出地位。

市場範圍
起始年份	2024
預測年份	2025-2034
起始值	79億美元
預測值	124億美元
複合年成長率	4.8％

按藥物類別分類，大環內酯在 2024 年佔據最大的市場佔有率，為 41%。它們的多功能性，加上注射劑和澆注劑等多樣化劑型，確保了它們廣泛應用於各種牲畜。

市場也按購買方式進行細分，非處方 (OTC) 類別獲得了顯著的關注，預計到 2034 年將達到 84 億美元。這些產品消除了對獸醫處方的需求，為寄生蟲控制提供了經濟高效且方便的解決方案。

口服驅蟲藥因其易於使用和成本效益而成為 2024 年的首選給藥途徑。片劑和粉末等產品無需專門的設備即可有效輸送活性成分。緩釋配方等創新進一步增強了它們的吸引力。

預計 2025 年至 2034 年期間，獸醫藥局的複合年成長率為 4.4%，成為驅蟲產品的重要配銷通路。它們的成長歸功於農民對定期驅蟲意識的提高，以及在專家指導下購買產品的便利性。

2024 年，美國佔據了北美市場的很大佔有率，價值 31 億美元，因為美國重視牲畜健康和動物寄生蟲感染的流行。

The Global Livestock Dewormers Market, valued at USD 7.9 billion in 2024, is projected to expand at a CAGR of 4.8% from 2025 to 2034. This growth is fueled by the increasing global demand for animal protein and dairy products, driven by population growth and urbanization. Rising meat and milk consumption necessitates effective herd health management to maximize productivity. Parasitic infestations in livestock significantly hinder growth and yield, emphasizing the critical role of dewormers in livestock healthcare. Stringent food safety regulations, government support for veterinary health, and growing awareness among farmers about the economic losses caused by parasitic infections are bolstering the market. Developing regions in Asia-Pacific, Latin America, and Africa are also contributing significantly, with expanding livestock populations and investments in veterinary infrastructure driving demand.

Livestock dewormers, or anthelmintics, target parasitic worms such as roundworms, tapeworms, and flukes in animals like cattle, sheep, goats, swine, and poultry. The cattle segment dominated the market, reaching USD 3.6 billion in 2024. Cattle-specific dewormers are in high demand due to the susceptibility of cattle to parasitic infections that affect growth, milk production, and overall health. The adoption of intensive farming practices and the growing emphasis on food safety further drive this segment's prominence.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$7.9 Billion
Forecast Value	$12.4 Billion
CAGR	4.8%

By drug class, macrocyclic lactones held the largest market share at 41% in 2024. These compounds, known for their broad-spectrum efficacy and long-lasting action, are effective against internal parasites. Their versatility, combined with diverse formulations like injectables and pour-ons, ensures their widespread use across livestock species.

The market is also segmented by mode of purchase, with the over-the-counter (OTC) category gaining significant traction and expected to reach USD 8.4 billion by 2034. OTC dewormers are popular among farmers due to their accessibility, affordability, and ease of use. These products eliminate the need for veterinary prescriptions, offering cost-effective and convenient solutions for parasitic control.

Oral dewormers emerged as the preferred route of administration in 2024, driven by their ease of use and cost-effectiveness. Products such as tablets and powders allow efficient delivery of active ingredients without specialized equipment. Innovations like slow-release formulations further enhance their appeal.

Veterinary pharmacies are expected to grow at a CAGR of 4.4% from 2025 to 2034, serving as a vital distribution channel for deworming products. Their growth is attributed to increased awareness among farmers about regular deworming and the convenience of purchasing products with expert guidance.

In 2024, the US accounted for a significant share of the North American market, valued at USD 3.1 billion, due to its focus on livestock health and the prevalence of parasitic infections in animals.

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing livestock population
  - 3.2.1.2 Rise in zoonotic diseases
  - 3.2.1.3 Supportive government policies
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Anthelmintic resistance
  - 3.2.2.2 Focus on organic and natural farming
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Animal Type, 2021 – 2034 ($ Mn)

5.1 Key trends
5.2 Cattle
5.3 Swine
5.4 Poultry
5.5 Other animal types

Chapter 6 Market Estimates and Forecast, By Drug Class, 2021 – 2034 ($ Mn)

6.1 Key trends
6.2 Benzimidazoles
6.3 Macrocyclic lactones
6.4 Imidazothiazoles
6.5 Other drug classes

Chapter 7 Market Estimates and Forecast, By Mode, 2021 – 2034 ($ Mn)

7.1 Key trends
7.2 OTC
7.3 Prescription

Chapter 8 Market Estimates and Forecast, By Route of Administration, 2021 – 2034 ($ Mn)

8.1 Key trends
8.2 Oral
8.3 Topical
8.4 Parenteral

Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 – 2034 ($ Mn)

9.1 Key trends
9.2 Veterinary pharmacies
9.3 Retail pharmacies
9.4 Online pharmacies

Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Netherlands
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 India
- 10.4.3 Japan
- 10.4.4 Australia
- 10.4.5 South Korea
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Argentina
10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE